Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction

NCT00061958 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

50

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Adenocarcinoma of the Esophagus
Stage III Esophageal Cancer
Stage IV Esophageal Cancer

Interventions

DRUG: arsenic trioxide

Sponsor

National Cancer Institute (NCI)